Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects / Q000502:physiology*; D001923:Brain Chemistry; D002090:Butyrophenones / Q000494:pharmacology; D003342:Corpus Striatum / Q000502:physiology; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D004296:Dopa Decarboxylase / Q000032:analysis; D004298:Dopamine / Q000502:physiology*; D006719:Homovanillic Acid / Q000032:analysis; D006801:Humans; D008781:Methyltyrosines / Q000494:pharmacology; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D010640:Phenothiazines / Q000494:pharmacology; D009435:Synaptic Transmission
D002090:Butyrophenones; D008781:Methyltyrosines; D010640:Phenothiazines; D004295:Dihydroxyphenylalanine; D000661:Amphetamine; D004296:Dopa Decarboxylase; D004298:Dopamine; D006719:Homovanillic Acid